Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-25 @ 2:32 AM
NCT ID:
NCT06224634
Eligibility Criteria:
Inclusion Criteria:
* Patients planning to start treatment with anti-IL-17 antibodies
Exclusion Criteria:
* Current pregnancy
* FEV1 \< 1.5L or less than 60% of predicted value expected.
* Previous anaphylactic shock or severe allergic reaction to medicine
* Uncontrolled hypertension
* Myocardial infarction or stroke within the last 3 months
* Known aortic aneurysm
* Recent eye surgery or risk of elevated intracranial pressure
* Treatment with systemic corticosteroids within 6 weeks
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06224634
Study Brief:
Protocol Section:
NCT06224634